Royal Brisbane and Women's Hospital, Department of Gastroenterology and Hepatology, Butterfield St., Herston, QLD 4029, Australia.
Mater Hospital Brisbane, Department of Gastroenterology and Hepatology, Raymond Terrace, South Brisbane, QLD 4101, Australia.
J Crohns Colitis. 2022 Aug 30;16(8):1335-1339. doi: 10.1093/ecco-jcc/jjac028.
Excluding superimposed enteric infection is critical in the management of acute severe ulcerative colitis [ASUC]. Whilst infection with Clostridium difficile and cytomegalovirus have been shown to increase colectomy and mortality rates, no data exist regarding the impact of common viral enteropathogens in ASUC. Our aim was to determine if viral enteric infection in ASUC alters the severity or outcomes of these episodes.
This was a retrospective review of cases presenting to a large tertiary centre. Data were obtained from an in-house, prospectively maintained inflammatory bowel disease database. We identified all ASUC cases treated between October 2015 and January 2021 and compared those testing positive for adenovirus 40/41, human rotavirus or norovirus GI by faecal multiplex polymerase chain reaction [PCR] to those testing negative.
We identified 147 patients with ASUC and faecal multiplex PCR testing for viral pathogens. In total, 22/147 patients [14.9%] tested positive, two of whom tested positive for two viruses. The infected and non-infected cohorts did not differ significantly with regard to admission C-reactive protein [81.7 vs 76.6, p = 0.77], Mayo endoscopic subscore [2.4 vs 2.3, p = 0.43], length of hospital admission [7.9 vs 7.9 p = 0.99], requirement for rescue therapy [59% vs 56%, p = 0.75] or colectomy rate [4.5% vs 4.1%, p = 0.69].
Infection with viral enteropathogens was common in our ASUC cohort, but did not appear to affect disease severity at presentation, the need for rescue therapy or the success rate of rescue therapy.
在急性重度溃疡性结肠炎(ASUC)的治疗中,排除重叠性肠道感染至关重要。虽然艰难梭菌和巨细胞病毒感染已被证明会增加结肠切除术和死亡率,但尚无关于 ASUC 中常见病毒性肠道病原体的影响的数据。我们的目的是确定 ASUC 中的病毒肠道感染是否会改变这些发作的严重程度或结局。
这是对一家大型三级中心就诊的病例进行的回顾性研究。数据来自内部前瞻性维持的炎症性肠病数据库。我们确定了在 2015 年 10 月至 2021 年 1 月期间接受治疗的所有 ASUC 病例,并将粪便多重聚合酶链反应(PCR)检测出腺病毒 40/41、人轮状病毒或诺如病毒 GI 阳性的患者与检测结果为阴性的患者进行比较。
我们确定了 147 例 ASUC 患者,并对病毒病原体进行了粪便多重 PCR 检测。在总共 147 例患者中,有 22 例(14.9%)检测结果为阳性,其中 2 例患者检测出两种病毒。感染组和未感染组在入院时 C 反应蛋白[81.7 与 76.6,p=0.77]、Mayo 内镜亚评分[2.4 与 2.3,p=0.43]、住院时间[7.9 与 7.9,p=0.99]、需要挽救性治疗[59%与 56%,p=0.75]或结肠切除术率[4.5%与 4.1%,p=0.69]方面无显著差异。
在我们的 ASUC 队列中,病毒肠道病原体感染很常见,但似乎不会影响就诊时的疾病严重程度、挽救性治疗的需求或挽救性治疗的成功率。